Anupam Rasayan India
- P/E
- 74.62
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 7.38%
- Debt to Equity
- 0.57
- EPS (TTM)
- ₹15.35
- Book Value
- ₹290.02
- Market Cap
- —
- P/E (TTM)
- 74.62
- P/B
- 3.95
- ROE
- 5.55%
- Dividend Yield
- 0.13%
- EBITDA
- ₹543 Cr
- 52W High
- ₹1,415.00
- 52W Low
- ₹1,053.60
- Day Range
- ₹1,137.00 – ₹1,152.50
- Volume
- 2,18,508
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹1,145.40 | 74.62 | ₹12,985 Cr | 3.95 | 0.13% | 5.55% | 7.38% | ₹2,535 Cr | ₹225 Cr | |
| Median 8 companies | ₹1,559.55 | 57.54 | ₹20,474 Cr | 5.00 | 0.18% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 41
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 21
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 29
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 83
- Strong
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Stock is trading at 4.05 times its book value
- Tax rate seems low
- Company has a low return on equity of 4.61% over last 3 years.
- Dividend payout has been low at 9.85% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 6 | 5 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 7 | 0 | 3 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 48.10
- Neutral
- MACD (12,26,9)
- −9.94
- Bullish
- SMA (50)
- 1,184.28
- Bearish
- SMA (200)
- 1,255.19
- Bearish
As of
Analyst Rating
3 of 4 analysts rate Buy, 0 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +23.87% |
|---|---|
| 3Y | +13.86% |
| 1Y | +64.58% |
| TTM | +51.74% |
Net profit
| 5Y | +25.97% |
|---|---|
| 3Y | +0.76% |
| 1Y | +38.75% |
| TTM | +14.80% |
Operating cash flow
| 5Y | +219.70% |
|---|---|
| 3Y | +4.58% |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −1.68 pp |
|---|---|
| 3Y | −4.66 pp |
| 1Y | −5.67 pp |
| TTM | −6.08 pp |
Revenue by year
| Mar 2019 | ₹502 Cr |
|---|---|
| Mar 2020 | ₹529 Cr |
| Mar 2021 | ₹811 Cr |
| Mar 2022 | ₹1,074 Cr |
| Mar 2023 | ₹1,602 Cr |
| Mar 2024 | ₹1,475 Cr |
| Mar 2025 | ₹1,437 Cr |
| Mar 2026 | ₹2,365 Cr |
Net profit by year
| Mar 2019 | ₹49.00 Cr |
|---|---|
| Mar 2020 | ₹53.00 Cr |
| Mar 2021 | ₹70.00 Cr |
| Mar 2022 | ₹152 Cr |
| Mar 2023 | ₹217 Cr |
| Mar 2024 | ₹167 Cr |
| Mar 2025 | ₹160 Cr |
| Mar 2026 | ₹222 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Anupam Rasayan India Ltd trades at ₹1,151.4 as of 2026-10-28 with a market cap of ₹13,108.67 Cr. The company has delivered strong TTM sales growth of 52% and TTM profit growth of 42%, but carries a rich PE of 75.01x and a modest ROE of 4.8%, presenting a mixed picture of high growth against stretched valuations and subdued return ratios.
- TTM revenue growth of 52% is exceptionally strong, indicating a sharp acceleration in top-line momentum compared to the 3-year sales CAGR of 14%
- TTM profit growth of 42% shows significant earnings recovery and operating leverage after a 3-year compounded profit CAGR of -2%
- 5-year compounded sales CAGR of 24% demonstrates a sustained long-term growth trajectory in the specialty chemicals space
- 5-year compounded profit CAGR of 19% reflects the company's ability to scale profitably over a longer horizon despite near-term earnings volatility
- Debt-to-equity ratio of 0.57 is manageable and suggests the balance sheet is not over-leveraged, providing room for future capex funding
- The stock is trading at ₹1,151.4, which is 18.6% below its 52-week high of ₹1,415, suggesting it has corrected from peak levels
- The company is expected to deliver a good upcoming quarter, which could act as a near-term positive catalyst for earnings sentiment
- Stock price CAGR of 11% over 3 years shows the market has rewarded the company's growth story with steady capital appreciation
- ROE of 4.8% is low, and the 3-year average ROE of roughly 5% indicates the company is generating poor returns on shareholders' equity
- ROCE of 7.47% is modest, suggesting the company's deployed capital is not generating strong economic returns relative to its cost of capital
- Price-to-book ratio of 3.97x (approximately 4.05x book value) is elevated for a company delivering sub-5% ROE, signaling a valuation-return mismatch
- Dividend yield of just 0.13% and a payout ratio of only 9.85% of profits over the last 3 years offer negligible income to shareholders
- 3-year compounded profit CAGR of -2% shows that until the recent TTM surge, earnings had been stagnant or declining
- Tax rate appears low, which if normalized upward could compress net margins and reduce the EPS base supporting the current valuation
- The stock is only 9.3% above its 52-week low of ₹1,053.6, indicating it has been under sustained selling pressure over recent months
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Anupam Rasayan promoters released pledges on over 1.16 crore shares across Oct 5-6, signalling improving promoter-level financial health. While the trend is clearly positive, encumbered shares still account for roughly 15% of share capital. No operational or sector-specific headwinds emerged this week. Continued pledge reduction would further strengthen investor confidence.
- Promoter pledge steadily reducing Oct 5
Rehash Industrial released a pledge on 50 lakh shares after repaying a Tata Capital loan, followed by Catalyst Trusteeship releasing 66.05 lakh shares on Oct 6. Combined 1.16 crore shares unlocked in two days.
- Encumbered shares still at 14.9% Oct 6
After the two pledge releases, remaining encumbered promoter shares stand at 1,69,66,785 representing 14.90% of total share capital — still a meaningful level to monitor.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 386 | 392 | 296 | 401 | 254 | 294 | 390 | 500 | 486 | 731 | 512 | 636 | 655 |
| Expenses | 285 | 285 | 216 | 308 | 201 | 214 | 266 | 356 | 362 | 596 | 385 | 498 | 493 |
| Operating Profit | 101 | 107 | 79 | 93 | 53 | 80 | 124 | 144 | 124 | 136 | 127 | 137 | 162 |
| OPM % | 26% | 27% | 27% | 23% | 21% | 27% | 32% | 29% | 26% | 19% | 25% | 22% | 25% |
| Other Income | 12 | 3 | 2 | 12 | 6 | 2 | −4 | 6 | 5 | 8 | 2 | 3 | 13 |
| Interest | 18 | 20 | 25 | 26 | 22 | 27 | 32 | 31 | 36 | 36 | 35 | 42 | 49 |
| Depreciation | 19 | 20 | 20 | 21 | 21 | 22 | 29 | 31 | 31 | 32 | 34 | 43 | 56 |
| PBT | 77 | 71 | 36 | 58 | 16 | 34 | 59 | 88 | 63 | 76 | 60 | 56 | 70 |
| Tax % | 32% | 31% | 28% | 30% | 25% | 10% | 9% | 29% | 23% | 24% | −1% | 0% | 27% |
| Net Profit | 52 | 49 | 26 | 40 | 12 | 31 | 54 | 63 | 48 | 57 | 61 | 56 | 51 |
| EPS (₹) | 3.59 | 3.78 | 1.68 | 2.82 | 0.36 | 1.52 | 2.56 | 4.05 | 3.1 | 3.9 | 4.31 | 3.75 | 3.39 |
Profit & Loss
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 502 | 529 | 811 | 1,074 | 1,602 | 1,475 | 1,437 | 2,365 | 2,535 |
| Expenses | 408 | 394 | 617 | 769 | 1,171 | 1,094 | 1,036 | 1,840 | 1,972 |
| Operating Profit | 93 | 135 | 194 | 305 | 431 | 381 | 401 | 526 | 563 |
| OPM % | 19% | 25% | 24% | 28% | 27% | 26% | 28% | 22% | 22% |
| Other Income | 19 | 11 | 26 | 8 | 10 | 30 | 11 | 18.17 | 26 |
| Interest | 24 | 45 | 69 | 31 | 63 | 89 | 112 | 149 | 162 |
| Depreciation | 23 | 29 | 52 | 60 | 71 | 80 | 102 | 140 | 165 |
| PBT | 66 | 72 | 100 | 222 | 308 | 242 | 198 | 254 | 261 |
| Tax % | 24% | 26% | 30% | 31% | 30% | 31% | 19% | 13% | — |
| Net Profit | 49 | 53 | 70 | 152 | 217 | 167 | 160 | 222 | 225 |
| EPS (₹) | 9.85 | 10.64 | 7.04 | 15.18 | 16.83 | 11.71 | 8.49 | 14.94 | 15.35 |
| Div. Payout % | 0% | 0% | 7% | 7% | 15% | 11% | 9% | 10% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 100 | 100 | 107 | 110 | 110 | 114 |
| Reserves | 432 | 515 | 1,473 | 1,627 | 2,265 | 2,651 | 2,740 | 3,188 |
| Borrowings | 694 | 847 | 423 | 836 | 822 | 1,069 | 1,373 | 1,867 |
| Other Liabilities | 146 | 252 | 301 | 327 | 584 | 772 | 1,045 | 2,843 |
| Total Liabilities | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 8,013 |
| Fixed Assets | 681 | 977 | 1,115 | 1,202 | 1,417 | 1,501 | 2,185 | 3,713 |
| CWIP | 191 | 101 | 43 | 44 | 120 | 609 | 216 | 114 |
| Investments | 0 | 0 | 0 | 149 | 67 | 67 | 9 | 19 |
| Other Assets | 451 | 586 | 1,140 | 1,496 | 2,173 | 2,424 | 2,860 | 4,167 |
| Total Assets | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 8,013 |
Cash Flow
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | 39 | 95 | 1 | −171 | 292 | 59 | −30 | 334 |
| Investing | −250 | −178 | −193 | −412 | −523 | −392 | −330 | −820 |
| Financing | 206 | 102 | 416 | 384 | 371 | 395 | 223 | 621 |
| Net Cash Flow | −6 | 19 | 224 | −199 | 140 | 62 | −137 | 135 |
| Free Cash Flow | −209 | −85 | −144 | −318 | 232 | −644 | −440 | −220 |
| CFO/EBITDA | 55 | 77 | 10 | −44 | 84 | 28 | 3 | 72 |
Ratios
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 89 | 92 | 95 | 95 | 143 | 186 | 148 |
| Inventory Days | 277 | 515 | 530 | 852 | 483 | 627 | 876 | 490 |
| Days Payable | 105 | 226 | 215 | 225 | 167 | 247 | 348 | 261 |
| Cash Conversion Cycle | 260 | 379 | 408 | 722 | 410 | 524 | 715 | 377 |
| Working Capital Days | 56 | 21 | 168 | 218 | 153 | 138 | 160 | 108 |
| ROCE % | — | 9% | 10% | 11% | 13% | 9% | 7% | 7% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Anupam Rasayan insights
67 extracted metrics across FY14–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q3 FY26 concall · Dec 2025Transcript PPT Recording
- 31 Aug 2026
- 24 Aug 2026
- 3 Jun 2026
- 2 Jun 2026
- 18 Mar 2026
- General announcements 3 Nov 2026
Frequently Asked Questions about Anupam Rasayan India
What does Anupam Rasayan India Ltd do?
Where is Anupam Rasayan India Ltd (ANURAS) listed?
Which sector does Anupam Rasayan India Ltd belong to?
What is the PE ratio of Anupam Rasayan India Ltd?
What is the 52-week high and low of Anupam Rasayan India Ltd?
Does Anupam Rasayan India Ltd pay dividends?
What is the Return on Equity (ROE) of Anupam Rasayan India Ltd?
Company Information
Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ANURAS.md for Anupam Rasayan India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.